Folic acid belladonna tablets combination therapy MAMIAI persistent diarrhea of infant observation.docVIP

 PAGE \* MERGEFORMAT 9 Folic acid belladonna tablets combination therapy MAMIAI persistent diarrhea of infant observation Of: Wang Deling, Zhuo Tang, Shi Shao-use, Zhang Yuanbo [Abstract] Objective To investigate the folate, belladonna tablets, combination therapy MAMIAI persistent diarrhea in infants and young children the clinical effect. Methods 86 patients aged 2 months to 2 years old, the average number of diarrheagt; 5 times / d were randomly divided for the treatment group and control group and the control group, 40 patients to be mommy loves and Smecta oral treatment of 46 cases to be folic acid, belladonna tablets, oral MAMIAI observed before and after treatment in children with clinical manifestations. Results 1 course After the control group was 60%, the treatment group was 96%, the difference was statistically significant (χ2 = 16.433, P lt;0.01). the treatment group than in the control group was significantly shorter duration, the average 48 h bowel evacuation and the number of times returned to normal, did not find belladonna of dry mouth, flushing, difficulty urinating, fever and altered mental status and other adverse reactions. Conclusions Folic acid, belladonna tablets, MAMIAI infants can significantly shorten the treatment of persistent diarrhea time. [Keywords:] folic acid, belladonna, Mummy love, infants, persistent diarrhea Promote the use of oral rehydration salts as (ORS) and other improvements in treatment of acute diarrheal disease mortality has decreased significantly, analysis of the current deaths in children with diarrhea and found that half of them died of persistent and intractable diarrhea and its consolidated disease, to further reduce the mortality of children with diarrhea, to reduce the impact of diarrhea on the growth and development [1]. I applied folic acid, belladonna tablets, combination therapy MAMIAI persistent diarrhea in infants achieved satisfactory results, the report is as follows . 1 Materials and